News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
151 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24193)
Month
January (2987)
February (3289)
March (3625)
April (3424)
May (3732)
June (3551)
July (2687)
August (3042)
September (3454)
October (3101)
November (3075)
December (2362)
Day
1 (115)
4 (191)
5 (173)
6 (155)
7 (166)
8 (89)
11 (158)
12 (169)
13 (151)
14 (157)
15 (126)
18 (206)
19 (202)
20 (188)
21 (157)
22 (105)
25 (168)
26 (210)
27 (162)
28 (209)
29 (167)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
18
19
20
21
22
25
26
27
28
29
Biotech Beach
ChromaDex, Inc. Announces Reverse Stock Split As Company Seeks To List Its Common Stock On The NASDAQ Capital Market
April 13, 2016
·
4 min read
Drug Development
DURECT Announces FDA Acceptance Of REMOXY NDA, PDUFA Date Of September 25, 2016
April 13, 2016
·
4 min read
Drug Development
PDS Biotechnology Corporation Reports Positive Phase 1 Study Results For PDS0101 Immunotherapy For HPV-Related Cancers
April 13, 2016
·
3 min read
Business
Oncternal Therapeutics Awarded Exclusive Worldwide License To ROR1 Antibody And Related Programs From University of California, San Diego (UCSD)
April 13, 2016
·
5 min read
Biotech Bay
IMPAX Labs Announces Availability of EMVERM (mebendazole) Chewable Tablets, 100 mg
April 13, 2016
·
8 min read
Business
Richard Hausmann Appointed As Elekta’s President And CEO
April 13, 2016
·
2 min read
Business
Mast Therapeutics Announces Agreement For Phase 2 Study Of AIR001 To Be Conducted By The Heart Failure Clinical Research Network
April 13, 2016
·
9 min read
Drug Development
Boehringer Ingelheim Release: Head-To-Head Study Demonstrating Gilotrif (Afatinib) Significantly Improved Clinical Outcomes Compared To Iressa (Gefitinib) In EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Published In The Lancet Oncology
April 13, 2016
·
11 min read
Drug Development
Therabron Receives Notice Of Allowance For New Patent Supporting The Recombinant CC10 Technology Platform
April 13, 2016
·
2 min read
Business
Intrexon Forms Two New Collaborations with Harvest Intrexon Enterprise Fund
April 13, 2016
·
5 min read
1 of 16
Next